Literature DB >> 3616905

[Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes].

O Schober, H H Günter, R Schwarzrock, H Hundeshagen.   

Abstract

In a retrospective study, the hematologic parameters of 296 patients treated with iodine-131 (average: 536 mCi) for carcinoma of the thyroid gland were evaluated with respect to the different doses applied. The average observation period was 65 months. The most frequent hematologic modification was thrombocytopenia which was found in 35%, followed by erythrocytopenia in 24% of cases. The normal concentration of leucocytes was decreased in 11% and increased in 23% of cases, however, the medium value calculated for all patients showed a decrease of leucocytes by 7%. Pancytopenias were found in 4.4% of cases. The most severe decreases were presented after high doses of radio-iodine (greater than or equal to 1000 mCi). Pancytopenia may be considered as one of the causes of the death of three patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3616905

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  4 in total

1.  EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

Authors:  Michael Lassmann; Heribert Hänscheid; Carlo Chiesa; Cecilia Hindorf; Glenn Flux; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07       Impact factor: 9.236

Review 2.  Papillary thyroid cancer.

Authors:  J H Yim; G M Doherty
Journal:  Curr Treat Options Oncol       Date:  2000-10

3.  Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.

Authors:  Tianpeng Hu; Zhaowei Meng; Guizhi Zhang; Qiang Jia; Jian Tan; Wei Zheng; Renfei Wang; Xue Li; Na Liu; Pingping Zhou; Arun Upadhyaya
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine

Authors:  Bircan Sönmez; Özlen Bektaş; Nergiz Erkut; Mehmet Sönmez
Journal:  Turk J Haematol       Date:  2021-03-22       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.